Breaking News on Pharmaceutical Technology

Latest news headlines

Products

Suppliers

Blast at Aesica London plant

20-Nov-2007 - Contract manufacturer Aesica has confirmed reports of a blast at its Ponders End facility in North London last night, hospitalising three workers.

CML snaps up API services firm

20-Nov-2007 - Cambridge Major Laboratories (CML) has bought up a Dutch supplier of active pharmaceutical ingredient (API) development services, creating one of the largest pharma chemistry development organisations in the western hemisphere.

Formulation tech goes Enterion

20-Nov-2007 - The Enterion capsule is quickly becoming big pharma's new best friend as the technology helps drug companies assess the feasibility of oral modified release formulations.

APIcross goes solo in drug delivery

19-Nov-2007 - Contract pharmaceutical development company Azopharma has carved out its drug delivery segment into a new company, APIcross Drug Delivery Technologies.

AMRI continues growth

15-Nov-2007 - Albany Molecular Research Inc (AMRI) recently turned in Q3 results, posting figures buoyed by continued demand for its pharmaceutical development services.

PharmEng opens new Canada plant

13-Nov-2007 - Canadian contract manufacturer PharmEng recently announced that its new specialised manufacturing facility in Nova Scotia is open for business.

NPIL to trim ex-Pfizer site

13-Nov-2007 - NPIL Pharma last week told workers at its former Pfizer plant in Morpeth, UK that the company is considering hiving off jobs in a bid to maintain the site's viability.

Pharmaceutical manufacturing: news in brief

09-Nov-2007 - In-PharmaTechnologist.com brings you a selection of other headlines from the pharmaceutical manufacturing industry.

Wacker expands further into biologics

09-Nov-2007 - Biopharmaceutical contract manufacturer Wacker will be expanding its German facility in Jena for €15m ($22m) as it meets demand for biologics.

West unscathed by Exubera shot - for now

08-Nov-2007 - West Pharmaceutical Services, one of the two firms responsible for manufacturing Pfizer's failed Exubera device, recently turned in its third quarter financials, so far avoiding any major dent from the company's decision to drop the inhalable insulin product.

Outsourcing-Pharma.com special focus

Inyx drama highlights crucial need for due diligence on contractors

31-Oct-2007 - There are lessons to be learned about the importance of rigorous due diligence of pharma contractors, now that Inyx' customers are facing possible supply issues and a scramble to find alternative manufacturers after the firm's collapse.

Outsourcing-Pharma.com special focus

Karma for big pharma? Sanofi-Aventis caught out by Inyx collapse

30-Oct-2007 - Sanofi-Aventis has had to take Inyx USA to court after it failed to deliver on a contract manufacturing and supply agreement, a situation that Aventis feared could "seriously harm its interests". There may be important lessons to be learned for all of big pharma.

Pharmaceutical manufacturing: news in brief

26-Oct-2007 - In-PharmaTechnologist.com brings you a selection of other headlines from the pharmaceutical manufacturing industry.

Gardasil vs Cervarix - winner gets UK supply contract

26-Oct-2007 - The race is on between cervical cancer vaccines Gardasil and Cervarix as they begin to battle it out to win a more than £100m a year supply contract with the UK Department of Health.

Wockhardt makes latest US move

25-Oct-2007 - Indian generics specialist Wockhardt is continuing its drive to strengthen its foothold in the US market, snapping up US firm Morton Grove Pharmaceuticals.

Pfizer not alone in feeling the heat of California fires

24-Oct-2007 - As the fires in California continue to rage, Pfizer and other pharma and biotech companies all over Southern California are bracing themselves for closures and even evacuations of their facilities.

Online drug discovery services database to be launched

18-Oct-2007 - A US start-up firm is gearing up to launch an online database where researchers can access a variety of drug discovery service providers across the globe.

Contract manufacturing news in brief

17-Oct-2007 - Microbix Biosystems, PacificGMP and Insulet have all recently announced new contract manufacturing news.

Meldex moves in Germany, inks new deal

17-Oct-2007 - Growing demand has prompted tableting specialist Meldex International, formerly BioProgress, to launch a new sales and distribution hub in Germany, with the UK firm also announcing a new manufacturing contract for its XGel film.

Weekly Comment

'We are not anti-Asia' says EU chemicals body

09-Oct-2007 - There have been more calls this month to tighten regulations on pharmaceutical ingredient suppliers in the wake of the recent safety concerns emanating from low-cost regions such as China and India. However, despite having recently established a dedicated 'China Taskforce', a major EU chemicals consortium insists that it has nothing against the region or its manufacturers.

Bavarian Nordic meets milestones

09-Oct-2007 - Denmark-based Bavarian Nordic has received an advance payment of $50m (€35.4m) from the US Government for meeting milestones in one of its smallpox vaccine supply contracts.

Inside India: special series

Pall nurturing its Indian presence

27-Sep-2007 - Pall Life Sciences gave Outsourcing-Pharma.com an update on its budding operations in India, one of the most promising markets for the firm, where the pharmaceutical industry is growing at a rate of nearly 9 per cent annually.

Evotec hives off chemical development biz

11-Sep-2007 - German firm Evotec has sold off its chemical and pharmaceutical development (CPD) business along with the associated facilities in the UK.

SAFC Wisconsin site keeps on growing

30-Aug-2007 - In the latest phase of growth at chemical firm SAFC's flagship high potency active pharmaceutical ingredients (HPAPIs) facility in Madison, Wisconsin, the site will be treated to another multi-million dollar expansion and new analytical testing equipment.

Lonza's China plan taking shape

30-Aug-2007 - Lonza's $200m (€147m) investment in China is continuing to shape up as the firm announced its new small-scale exclusive synthesis manufacturing plant will be up and running next month.

Sign up for your free newsletter